Evidence map›Paper›PMID 33628955›Full record

ArticleJournal of preventive medicine and hygiene2020

Universal Health Coverage to counteract the economic impact of the COVID-19 infection: current practices and ethical challenges.

Masoud Behzadifar, Mohammad-Hasan Imani-Nasab, Mariano Martini, Mahboubeh Khaton Ghanbari, Ahad Bakhtiari, Nicola Luigi Bragazzi

Open access · greenAbstract read
In one paragraph

Article in Journal of preventive medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Path Analysis to Assess Socio-Economic and Mitigation Measure Determinants for Daily Coronavirus Infections.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Masoud BehzadifarSocial Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mohammad-Hasan Imani-NasabSocial Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mariano MartiniDepartment of Health Sciences, University of Genoa, Italy.
Mahboubeh Khaton GhanbariHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Ahad BakhtiariDepartment of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Nicola Luigi BragazziDepartment of Mathematics and Statistics, York University, Toronto, ON, Canada.
Lorestan University of Medical Sciences · IRIran University of Medical Sciences · IRTehran University of Medical Sciences · IRUniversity of Genoa · ITYork University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In late December 2019, the first case of an emerging coronavirus was identified in the city of Wuhan, Hubei province, in mainland China. The novel virus appears to be highly contagious and is rapidly spreading worldwide, becoming a pandemic. The disease is causing a high toll of deaths. Effective public health responses to a new infectious disease are expected to mitigate and counteract its negative impact on the population. However, time and economic-financial constraints, as well as uncertainty, can jeopardize the answer. The aim of the present paper was to discuss the role of Universal Health Coverage to counteract the economic impact of the COVID-19 infection. Appropriate financing of the health system and ensuring equitable access to health services for all can, indeed, protect individuals against high medical costs, which is one of the most important goals of any health system. Financing profoundly affects the performance of the health system, and any policy that the health system decides to implement or not directly depends on the amount of available funding. Developed countries are injecting new funding to cope with the disease and prevent its further transmission. In addition to psychological support and increased societal engagement for the prevention, control, and treatment of COVID-19, extensive financial support to governments by the community should be considered. Developed and rich countries should support countries that do not have enough financial resources. This disease cannot be controlled and contained without international cooperation. The experience of the COVID-19 should be a lesson for further establishing and achieving universal health coverage in all countries. In addition to promoting equity in health, appropriate infrastructure should be strengthened to address these crises. Governments should make a stronger political commitment to fully implement this crucial set of policies and plans.

Indexed as

COVID-19Developing CountriesGlobal HealthHealth Services AccessibilityHumansInternational CooperationPandemicsPublic HealthUniversal Health InsuranceCOVID-19Economic crisisEthical issuesHealth crisisHealth financingHealth policyUniversal health coverage

Identifiers

PMID33628955
PMCPMC7888394
OpenAlexW3133013681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.